Randomized phase III study of irinotecan and 5-FU / FA with or without cetuximab in the first line treatment of patients with metastatic colorectal cancer (mCRC): the CRYSTAL trial. - VanCutsem,E.; Nowacki,M.; Lang,I. (J Clin Oncol, 2007)